The Team

Beyond their expertise in optogenetics, each and every member of our team possesses a fierce desire to make a previously unimaginable difference to the lives of those suffering from disorders of the nervous system. This ambition is what drives the team and creates the incredibly exciting environment at Circuit Therapeutics.
  • Fred Moll, MD
    CEO and Chairman of the Board

    Dr. Moll is an entrepreneur with formidable experience in the area of medical devices. He founded Intuitive Surgical, the world leader in surgical robotics, and has since founded Hansen Medical and Auris Surgical Robotics. Dr. Moll also founded Origin Medsystems, Inc, which later became an operating company within Guidant Corporation. He is currently on the boards of several influential healthcare companies. Dr. Moll holds a BA from the University of California, Berkeley, an MS from Stanford University, and an MD from the University of Washington School of Medicine.

  • Karoly Nikolich, PHD
    Founder

    Dr. Nikolich is Founder of Circuit Therapeutics and has been with the company since its inception. He has extensive experience in biotechnology companies, primarily in the area of neuroscience. Dr. Nikolich previously led work in neuroscience at Genentech, was VP of Research at Lynx Therapeutics, and has founded and led companies, including AGY Therapeutics, Neurofluidics, and Amnestix. He is a Consulting Professor at Stanford University, serves on the boards of several companies, and is an advisor to venture funds. Dr. Nikolich conducted his doctoral studies at Eötvös University of Sciences in Budapest, Hungary, and postdoctoral research at Tulane University and at UCSF.

  • Michael Kaplitt, MD, PHD
    CSO

    Dr. Kaplitt is an internationally recognized expert in gene therapy and molecular neurobiology. He co-developed the use of AAV technology for gene transfer in the nervous system more than 20 years ago, and as a practicing neurosurgeon he also performed the first human gene therapy for Parkinson’s Disease. He retains his laboratory at Weill Cornell Medical College where he also continues to perform functional neurosurgery procedures in addition to leading scientific activities at Circuit Therapeutics. Dr. Kaplitt has received numerous awards for both his research and clinical work. After completing an undergraduate degree in molecular biology and Russian Studies, he received his PhD from Rockefeller University and his MD from Cornell Medical College. Dr. Kaplitt joined Circuit Therapeutics in 2013.

  • Dan Andersen
    VP, Engineering

    Dan Andersen is a serial entrepreneur, seasoned engineer and medical device executive with 20 years of experience and is an expert in the areas of biophotonics and photomedicine. He has helped bring 12 products into clinical use, which have helped millions of patients worldwide and been recognized by several innovation awards. Previously, Dan was a founder and director at OptiMedica, which Abbott acquired in 2013. Prior to that, he co-founded Sciton and Westland Optical Works, and held technical and management positions at Coherent after receiving his BS in Physics from the University of Arizona. He has authored 14 articles in scientific and medical journals, and is an inventor on over 70 issued US patents and published applications. Dan joined Circuit Therapeutics in 2012.

Scientific Advisors

A great team includes support from great advisors with incredible experience and awe-inspiring passion
  • Karl Deisseroth, MD, PhD

    Dr. Deisseroth is the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University. His pioneering work has been at the foundation of the field of optogenetics, opening up new ways to understand neural circuit function and dysfunction in neurological and psychiatric disease. He is a Howard Hughes Medical Institute Investigator, a member of the National Academy of Sciences, and has received prestigious awards, including the Nakasone Prize. Dr. Deisseroth received his PhD and MD from Stanford University. He is a Co-Founder of Circuit Therapeutics.

  • Scott Delp, PhD

    Dr. Delp is the James H. Clark Professor at Stanford University in the Departments of Bioengineering, Mechanical Engineering, and, by courtesy, Orthopedic Surgery. He is Founding Chair of the Department of Bioengineering and Co-Director of the Center for Biomedical Computation at Stanford University. Dr. Delp’s work draws on computational mechanics, medical imaging, and neuromuscular biology to improve treatments for neurologic and musculoskeletal diseases. His highly realistic simulations of the musculoskeletal system have been used to study neural control of movement and mechanisms of musculoskeletal diseases and to design surgeries and medical devices. He received his PhD from Stanford University in Mechanical Engineering. Dr. Delp is a Co-Founder of Circuit Therapeutics.

  • Anatol Kreitzer, PhD

    Dr. Kreitzer is Associate Professor of Physiology and Neurology at University of California, San Francisco and Associate Investigator at the Gladstone Institutes. His research focuses on understanding the function of the basal ganglia, particularly in the context of disorders including Parkinson’s Disease. He has published in high profile journals and was honored with the Young Investigator Award from the Society of Neuroscience. Dr. Kreitzer earned his PhD at Harvard University and conducted postdoctoral research at Stanford University.

  • Rob Malenka, MD, PhD

    Dr. Malenka is the Nancy Friend Pritzker Professor in Psychiatry & Behavioral Sciences at Stanford University and is Deputy Director of the Stanford Neurosciences Institute. He was the former co-Director at the Stanford Institute for Neuro-Innovation and Translational Neurosciences at the Stanford University School of Medicine and Associate Chair of the Department of Psychiatry and Behavioral Sciences. Dr. Malenka has been elected as a Member of the National Academy of Sciences, amongst other prestigious honors. His work focuses on understanding molecular mechanisms of synaptic plasticity and synaptic mechanisms underlying addiction and psychiatric disorders. He received his PhD and MD from Stanford University School of Medicine. Dr Malenka is a Co-Founder of Circuit Therapeutics.

  • Thomas Südhof, MD

    Dr. Südhof is a renowned scientist and winner of the Nobel Prize in Physiology or Medicine 2013 for his fundamental work understanding neuronal communication. Dr. Südhof is the Avram Goldstein Professor in the Stanford University School of Medicine and Professor, by courtesy, of Neurology and of Psychiatry and Behavioral Sciences; he is also a Howard Hughes Medical Institute investigator. He was formerly at the University of Texas Southwestern Medical Center at Dallas, earned his MD from Georg-August-Universität in Göttingen and performed postdoctoral studies at the Max Planck Institute for Biophysical Chemistry. He has received numerous honors including the Nobel Prize (2013), the Lasker Award (2013), and the Kavli Prize (2010), and he is a Member of the National Academy of Sciences. Dr. Südhof is a Co-Founder of Circuit Therapeutics.

Get in Touch

Have questions or simply looking to find out more about partnering with us? Pick up the phone or send a quick message to find out more about our vision or partnering with us.